Rheumatoid regulatory factor in the blood of rats immunized with autologous lymphocytes, activated in vitro by heterologous lymphocytes
- Authors: Kryazhevskikh A.V.1,2, Abisheva N.N.1,2
-
Affiliations:
- Udmurt Federal Research Center, Ural Branch, Russian Academy of Sciences
- Udmurt State University
- Issue: Vol 28, No 3 (2025)
- Pages: 449-454
- Section: SHORT COMMUNICATIONS
- URL: https://journals.rcsi.science/1028-7221/article/view/319886
- DOI: https://doi.org/10.46235/1028-7221-17142-RRF
- ID: 319886
Cite item
Full Text
Abstract
The approaches to prevention of acute and chronic transplant rejection are among the important challenges in clinical transplantology and regenerative medicine. For more than a century, induction of tolerance to natural and artificial transplant antigens has been a desired goal. Recently, anti-lymphocytic antibodies to activated lymphocytes, called regulatory rheumatoid factor (regRF), are shown to be involved in control of autoreactive lymphocytes under normal conditions, thus maintaining natural immune tolerance. A relatively rapid increase in the level of regRF in the blood (3-5 days) after immunization is observed during autotransplantation. Its early rise is also associated with non-reactivity of animals to experimentally induced autoimmune disorders. The aim of our study was to search an opportunity of regRF production in rats by injecting autologous lymphocytes activated in vitro by a heterologous antigen (murine lymphocytes). To achieve this result, a group of rats was immunized intravenously with a mixed culture of autologous and heterologous (murine) lymphocytes (MLC), after 5 days of co-incubation. Another group was immunized with murine lymphocytes only. RegRF in the blood was determined by days 3, 5, 7, 14, 21, 28 and 35 after immunization. It was hypothesized that the intravenous injection of autologous MLC-activated rat lymphocytes and mouse lymphocytes to the rats would cause an early regRF response to autologous lymphocytes, and a later response to heterologous mouse lymphocytes. On average, the regRF titer in rats following immunization with murine lymphocytes did not show significant changes. However, a significant increase in the standard deviation was seen only on day 7, thus indicating to a pronounced individual response of rats to the injection of heterologous murine lymphocytes. Immunization of animals with MLC-activated cells caused a two-phase increase of regRF in blood observed on days 5 and 21. An increase in regRF on day 5 after MLC immunization suggests a response to autologous lymphocytes activated by a heterologous antigen. The obtained results open up a prospect for further research aimed at developing novel techniques for inducing acquired tolerance.
Full Text
##article.viewOnOriginalSite##About the authors
Anastasia V. Kryazhevskikh
Udmurt Federal Research Center, Ural Branch, Russian Academy of Sciences; Udmurt State University
Author for correspondence.
Email: krav526@gmail.com
Research Engineer, Laboratory of Biocompatible Materials, Postgraduate Student, Department of Immunology and Cell Biology
Russian Federation, Izhevsk, Udmurt Republic; Izhevsk, Udmurt RepublicN. N. Abisheva
Udmurt Federal Research Center, Ural Branch, Russian Academy of Sciences; Udmurt State University
Email: krav526@gmail.com
PhD (Biology), Senior Researcher, Laboratory of Biocompatible Materials, Senior Researcher, Laboratory of Molecular and Cellular Immunology, Associate Professor, Department of Immunology and Cell Biology
Russian Federation, Izhevsk, Udmurt Republic; Izhevsk, Udmurt RepublicReferences
- Бедулева Л.В., Сидоров А.Ю., Абишева Н.Н., Гильманова Л.У., Горбушина А.Н. Метод определения отдельной популяции ревматоидного фактора с иммунорегуляторными свойствами» // Российский иммунологический журнал, 2020. Т. 23, № 2. С. 187-190. [Beduleva L.М., Sidorov A.Yu., Abisheva N.N., Gilmanova L.U., Gorbushina A.N. Detection of immunoregulatory rheumatoid factor. Rossiyskiy immunologicheskiy zhurnal = Russian Journal of Immunology, 2020, Vol. 23, no. 2, pp. 187-190. (In Russ.)] doi: 10.46235/1028-7221-267-DOI.
- Cкворцова Е.В., Синенко С.А., Зенин В.В., Томилин А.Н. Получение регуляторных дендритных клеток из индуцированных плюрипотентных стволовых клеток мыши для их использования в моделях трансплантации тканей // Гены и клетки, 2019. Т. 14. С. 214-215. [Skvortsova E.V., Sinenko S.A., Zenin V.V., Tomilin A.N. Obtaining regulatory dendritic cells from induced pluripotent stem cells of mice for their use in tissue transplantation models. Geny i kletki = Genes and Cells, 2019, Vol. 14, pp. 214-215. (In Russ.)]
- Andre C., Heremans J.F., Vaerman J.P., Cambiaso C.L. A mechanism for the induction of immunological tolerance by antigen feeding: antigen-antibody complexes. J. Exp. Med., 1975, Vol. 142, no. 6, pp. 1509-1519.
- Beduleva L., Menshikov I., Stolyarova E., Fomina K., Lobanova O., Ivanov P., Terentiev A. The rheumatoid factor in idiotypic regulation of autoimmunity. Int. J. Rheum. Dis., 2015, Vol. 18, pp. 408-420.
- Benichou G., Tonsho M., Tocco G., Nadazdin O., Madsen J.C. Innate immunity and resistance to tolerogenesis in allotransplantation. Front. Immunol., 2021, Vol. 3, 73. doi: 10.3389/fimmu.2012.00073.
- Bercovici N., Delon J., Cambouris C., Escriou N., Debre P., Liblau R.S. Chronic intravenous injections of antigen induce and maintain tolerance in T cell receptor-transgenic mice. Eur. J. Immunol., 1999, Vol. 29, no. 1, pp. 345-354.
- Heeger P.S., Dinavahi R. Transplant immunology for non-immunologist. Mt. Sinai J. Med., 2012, Vol. 79, pp. 376-387.
- Kholodenko I.V., Kholodenko R.V., Lupatov A.Yu., Yarygin K.N. Cell therapy as a tool for induction of immunological tolerance after liver transplantation. Bull. Exp. Biol. Med., 2018, Vol. 165, no. 4, pp. 554-563.
- Lu J., Li P., Du X., Liu Y., Zhang B., Qi F. Regulatory T cells induce transplant immune tolerance. Transpl. Immunol., 2021, Vol. 67, 101411. doi: 10.1016/j.trim.2021.101411.
- Martinez O.M., Rosen H. R. Basic Concepts in transplant immunology. Liver Transpl., 2005, Vol. 11, no. 4, pp. 370-381.
- Romano M., Fanelli G., Albany C.J., Giganti G., Lombardi G. Past, present, and future of regulatory T cell therapy in transplantation and autoimmunity. Front. Immunol., 2019, Vol. 10, 43. doi: 10.3389/fimmu.2019.00043.
- Romano M., Sim L.T., Lesley A.S., Giovanna L. Treg therapy in transplantation: a general overview. Transpl. Int., 2017, Vol. 30, no. 8, pp. 745-753.
- Sidorov A., Beduleva L., Menshikov I., Terentiev A., Stolyarova E., Abisheva N. Fc fragments of immunoglobulin G are an inductor of regulatory rheumatoid factor and a promising therapeutic agent for rheumatic diseases. Int. J. Biol. Macromol., 2017, Vol. 95, pp. 938-945.
Supplementary files
